How Encompass Health’s New Lake Worth Hospital and Bed Additions May Impact Encompass Health (EHC) Investors
- Encompass Health recently opened Encompass Health Rehabilitation Hospital of Lake Worth and reported third-quarter 2025 results that showed revenue growth, three new hospitals and 39 additional beds.
- This expansion, alongside tailwinds from digital healthcare adoption and rising demand from an aging population, highlights how Encompass Health is positioning its rehab network for longer-term growth in complex post-acute care.
- We’ll now examine how the latest hospital opening and bed additions may influence Encompass Health’s existing investment narrative and outlook.
AI is about to change healthcare. These 29 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Encompass Health Investment Narrative Recap
To own Encompass Health, you need to believe that rising demand for complex inpatient rehab and the company’s expanding hospital network can outweigh pressures on staffing and reimbursement. The latest Lake Worth opening, alongside Q3 2025 revenue growth and new beds, supports the near term growth catalyst of adding capacity, but it does not materially change the key risk that labor shortages and wage inflation could constrain margins and limit how quickly that new capacity can be converted into sustainable earnings.
Among recent developments, the opening of Encompass Health Rehabilitation Hospital of Lake Worth is most directly tied to this growth story, adding a 50 bed facility at a time when the company is already ramping up new hospitals and beds. For investors focused on the catalyst of unmet demand in post acute care, this sort of incremental capacity, combined with improving admissions in complex conditions, helps illustrate how Encompass Health is attempting to translate demographic tailwinds into higher throughput across its network.
Yet investors should also be aware that persistent nursing and therapist shortages could still limit how fully these new beds are staffed and utilized...
Read the full narrative on Encompass Health (it's free!)
Encompass Health's narrative projects $7.2 billion revenue and $711.6 million earnings by 2028.
Uncover how Encompass Health's forecasts yield a $140.33 fair value, a 31% upside to its current price.
Exploring Other Perspectives
Three members of the Simply Wall St Community currently value Encompass Health between US$140 and US$366 per share, highlighting very different expectations for future returns. Against that backdrop, the company’s heavy investment in new hospitals and beds, combined with ongoing labor and reimbursement risks, gives you several distinct scenarios for how its inpatient rehab focus could affect long term performance, so it is worth comparing multiple viewpoints before deciding how this fits in your portfolio.
Explore 3 other fair value estimates on Encompass Health - why the stock might be worth just $140.33!
Build Your Own Encompass Health Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Encompass Health research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Encompass Health research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Encompass Health's overall financial health at a glance.
Contemplating Other Strategies?
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
- Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
- The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
- Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com